VIATRIS INC. Common Stock, Dividends, Per Share, Cash Paid
VIATRIS INC. (VTRS) reported Common Stock, Dividends, Per Share, Cash Paid of $0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareCashPaid · last filed 2026-08-06
- VIATRIS INC. common stock, dividends, per share, cash paid for the quarter ending 2026-06-30 was $0.12, a 0.00% change year-over-year.
- VIATRIS INC. common stock, dividends, per share, cash paid for the quarter ending 2026-03-31 was $0.12, a 0.00% change year-over-year.
- VIATRIS INC. common stock, dividends, per share, cash paid for the quarter ending 2025-12-31 was $0.12, a 0.00% change year-over-year.
- VIATRIS INC. common stock, dividends, per share, cash paid for the quarter ending 2025-09-30 was $0.12, a 0.00% change year-over-year.
- VIATRIS INC. common stock, dividends, per share, cash paid for fiscal 2025 was $0.48, a 0.00% change from fiscal 2024.
- VIATRIS INC. common stock, dividends, per share, cash paid for fiscal 2024 was $0.48, a 0.00% change from fiscal 2023.
- VIATRIS INC. common stock, dividends, per share, cash paid for fiscal 2023 was $0.48, a 0.00% change from fiscal 2022.
- VIATRIS INC. common stock, dividends, per share, cash paid for fiscal 2022 was $0.48, a 45.45% increase from fiscal 2021.
| Period end | Common Stock, Dividends, Per Share, Cash Paid | Common Stock, Dividends, Per Share, Cash Paid 3 month | Common Stock, Dividends, Per Share, Cash Paid 6 month | Common Stock, Dividends, Per Share, Cash Paid 9 month | Common Stock, Dividends, Per Share, Cash Paid 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.12 10-Q · filed 2026-08-06 | $0.24 10-Q · filed 2026-08-06 | $0.36 derived: sum of 3 quarters · filed 2026-08-06 | $0.48 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-05-04 | $0.12 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | $0.12 10-Q · filed 2026-08-06 | $0.24 derived: sum of 2 quarters · filed 2026-08-06 | $0.36 derived: sum of 3 quarters · filed 2026-08-06 | $0.48 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.12 10-Q · filed 2026-08-06 | $0.24 derived: sum of 2 quarters · filed 2026-08-06 | $0.36 derived: sum of 3 quarters · filed 2026-08-06 | $0.48 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.12 10-Q · filed 2026-08-06 | $0.24 derived: sum of 2 quarters · filed 2026-08-06 | $0.36 10-Q · filed 2025-11-06 | $0.48 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.12 10-Q · filed 2026-08-06 | $0.24 10-Q · filed 2026-08-06 | $0.36 derived: sum of 3 quarters · filed 2026-08-06 | $0.48 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.12 10-Q · filed 2026-05-07 | $0.24 derived: sum of 2 quarters · filed 2026-05-07 | $0.36 derived: sum of 3 quarters · filed 2026-05-07 | $0.48 derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 10-Q · filed 2025-11-06 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.12 10-K · filed 2026-02-26 | $0.24 10-Q · filed 2025-08-07 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 10-K · filed 2026-02-26 | |
| 2023-12-15 | $0.12 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 10-Q · filed 2024-11-07 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-09-15 | $0.12 10-K · filed 2024-02-28 | ||||
| 2023-08-04 | $0.12 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | $0.12 10-K · filed 2026-02-26 | $0.24 10-Q · filed 2024-08-08 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-06-16 | $0.12 10-K · filed 2024-02-28 | ||||
| 2023-03-31 | $0.12 10-K · filed 2026-02-26 | $0.24 derived: sum of 2 quarters · filed 2026-02-26 | $0.36 derived: sum of 3 quarters · filed 2026-02-26 | $0.48 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-03-17 | $0.12 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | $0.12 10-K · filed 2025-02-27 | $0.24 derived: sum of 2 quarters · filed 2025-02-27 | $0.36 derived: sum of 3 quarters · filed 2025-02-27 | $0.48 10-K · filed 2025-02-27 | |
| 2022-12-16 | $0.12 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $0.12 10-K · filed 2025-02-27 | $0.24 derived: sum of 2 quarters · filed 2025-02-27 | $0.36 10-Q · filed 2023-11-08 | ||
| 2022-09-16 | $0.12 10-K · filed 2024-02-28 | ||||
| 2022-06-30 | $0.12 10-K · filed 2025-02-27 | $0.24 10-Q · filed 2023-08-07 | |||
| 2022-06-16 | $0.12 10-K · filed 2024-02-28 | ||||
| 2022-03-31 | $0.12 10-K · filed 2025-02-27 | ||||
| 2022-03-16 | $0.12 10-K · filed 2024-02-28 | ||||
| 2021-12-31 | $0.33 10-K · filed 2024-02-28 | ||||
| 2021-12-16 | $0.11 10-K · filed 2024-02-28 | ||||
| 2021-09-16 | $0.11 10-K · filed 2024-02-28 | ||||
| 2021-06-16 | $0.11 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |